Choosing the wrong mold test is one of the most common and costly mistakes homeowners and building managers make. A gravity-plate DIY kit cannot tell you whether your home's mold burden is dangerous. A single air sample taken on a calm day might miss the problem entirely. This guide cuts through the confusion: every major mold testing methodology explained, compared, and evaluated against the science — so you can get the right answer for your specific situation, not just a number on a lab report.
A thorough visual inspection by a trained professional is an essential first step in any mold assessment — but it has documented and significant limitations that make it insufficient as the sole evaluation method in many scenarios:
How it works: A calibrated pump pulls a known volume of air (typically 75–150 liters) through a cassette containing an adhesive-coated substrate (polycarbonate or acrylic slide). Airborne particles — including mold spores, pollen, debris, and fibers — impact the substrate and are trapped. The cassette is sent to an accredited laboratory, where an analyst counts and identifies spores by morphology under optical microscopy at 400–600× magnification.
What it measures: Concentration of airborne viable and non-viable spores at the moment of sampling, expressed as spores per cubic meter of air (spores/m³). Common cassette brands include Air-O-Cell (Zefon), Bio-Tape, and Allergenco-D. Results are provided as total counts by genus — Aspergillus/Penicillium (indistinguishable morphologically), Cladosporium, Alternaria, Curvularia, Chaetomium, basidiospores, etc.
Best use case: Establishing whether indoor air contains elevated mold concentrations compared to an outdoor control sample; screening for elevated total spore counts; post-remediation clearance testing (IICRC S520 protocol requires air sampling).
Limitations: Point-in-time snapshot — results reflect conditions at that specific moment, which are highly affected by recent HVAC activity, weather, building disturbance, and seasonal outdoor baseline. Cannot distinguish Aspergillus from Penicillium morphologically. Does not detect dead spores or fragmented mold particles (which retain allergenic/inflammatory activity). Cannot identify Stachybotrys reliably because its heavy, sticky spores rarely become airborne without disturbance.
Turnaround: Standard 3–5 business days; rush 24–48 hours.
How it works: The Andersen sampler uses a multi-stage cascade impactor with culture media plates at each stage, sized to capture particles of different aerodynamic diameters. Air is drawn through the sampler and viable mold spores impact and grow on the culture media. After 5–10 days of incubation, colony counts are made per stage, and colonies can be sub-cultured for species-level identification.
What it measures: Viable (living, culturable) airborne mold spores only — expressed as colony-forming units per cubic meter (CFU/m³). Provides species-level identification from cultures with high taxonomic precision.
Best use case: When species-level confirmation of viable airborne mold is essential (clinical investigation, occupational health surveys, research). Required for OSHA-compliant workplace air quality surveys.
Limitations: Captures only living spores (viable fraction) — non-viable spores and fragments, which can still cause allergic and inflammatory responses, are not counted. Results require 5–10 day culture incubation — not suitable for rapid assessment. Some mold species grow slowly or require specialized media (e.g., Stachybotrys requires selective media). More expensive and technically demanding than cassette sampling.
How it works: A strip of clear adhesive tape is pressed onto a suspected mold surface, lifted, and adhered to a microscopy slide or placed in a collection container. Alternatively, a sterile swab is rubbed across the surface and placed in transport media. The laboratory mounts tape lifts directly for microscopic examination or cultures swabs on appropriate media.
What it measures: Presence and morphological identification of mold on visible surface growth. Provides genus-level (and sometimes species-level via culture) identification of the mold directly colonizing the surface.
Best use case: Confirming that a suspicious stain or growth is genuinely mold; identifying species on a known mold-affected surface; characterizing the dominant genus for remediation planning; legal documentation of visible mold.
Limitations: Only samples visible surface mold — cannot detect hidden or subsurface growth. Does not provide quantitative data on the extent of infestation. Tape lift results showing mold do not indicate whether that mold is creating problematic airborne concentrations. A positive result requires remediation; a negative result does not rule out mold elsewhere in the structure.
How it works: A portion of the suspect building material itself — drywall, wood, insulation, carpet, ceiling tile — is physically removed and submitted to the laboratory in a sealed container. The lab homogenizes the material and performs direct examination under microscopy and/or culture on selective media.
What it measures: Presence of mold within building materials, not just on their surface. Provides genus and species identification. Can differentiate between a surface contaminant and deeply colonized, structurally compromised material.
Best use case: Determining the extent of mold penetration into porous materials; pre-remediation planning to determine whether materials can be cleaned or must be replaced; legal documentation of structural mold involvement.
Limitations: Invasive — requires physical removal of building material. Results represent a single location and may not reflect the extent of surrounding contamination. Does not provide concentration data directly comparable to air sampling. Requires careful sampling technique to avoid cross-contamination.
How it works: The ERMI was developed by the EPA (Environmental Protection Agency) as a standardized, reproducible measure of indoor mold burden based on settled-dust analysis. Settled house dust — collected from a defined area of carpet using a vacuum with a special collection cassette, or from a composite surface wipe — is submitted for laboratory analysis using MSQPCR (mold-specific quantitative PCR). The EPA's panel tests for 36 specific mold species (26 Group 1 "water-damage indicator" species and 10 Group 2 "reference" species commonly found in all homes).
The ERMI score formula: ERMI = Log sum(Group 1 species counts) − Log sum(Group 2 species counts). The national reference range spans approximately −10 to +20, with higher scores indicating greater prevalence of water-damage-associated mold species relative to ubiquitous reference species. The national median ERMI for US homes is approximately 0 (neither wet nor dry), with scores above +5 considered potentially problematic and scores above +8 linked in research to elevated health effects.
HERTSMI-2 subset: The Health Effects Roster of Type-Specific Formers of Mycotoxins and Inflammagens (HERTSMI-2) is a simplified 5-species subset of the ERMI panel: Aspergillus penicillioides, Aspergillus versicolor, Chaetomium globosum, Stachybotrys chartarum, and Wallemia sebi. HERTSMI-2 scoring: ≤11 = acceptable for most occupants; 12–15 = caution zone, reassess occupancy for sensitive individuals; ≥16 = remediation needed before occupancy of sensitive individuals. HERTSMI-2 is commonly used by physicians treating mold-related illness (CIRS protocols) as a re-occupancy criterion.
Best use case: Comprehensive indoor mold burden assessment integrating exposure over weeks to months (not a point-in-time snapshot like air sampling); HUD housing health surveys; clinical assessment of mold illness; real estate transactions requiring historical mold burden data; post-remediation verification when combined with air sampling.
Limitations: Does not identify active (current) mold growth locations — measures historical settled dust. Not sensitive for detecting isolated or recent contamination. Requires proper dust collection technique for valid results. Cannot replace air sampling for post-remediation clearance under IICRC S520 protocol. Not standardized by AIHA the way air sampling is.
Research backing: ERMI has been validated in multiple HUD housing studies, the Indoor Air Quality study of asthmatic children (Vesper et al.), and the National Survey of Lead and Allergens in Housing. ERMI scores correlated significantly with asthma symptom burden and emergency department visits in inner-city asthmatic children cohorts.
How it works: Quantitative PCR (polymerase chain reaction) detects and quantifies mold DNA directly from environmental samples — typically collected via ERMI-type dust vacuum, air cassette, or HVAC filter extract. The EMMA panel (offered by Real Time Laboratories and similar providers) simultaneously tests for 12–15 mold species most relevant to human health and 10–15 mycotoxins in a single analytical run. Species are detected by amplification of specific genetic sequences unique to each target organism, enabling unambiguous species-level identification without culture or morphological analysis.
What it measures: DNA quantity of each target mold species (expressed as equivalent spore counts per sample); presence/absence and semi-quantitative levels of mycotoxins including aflatoxins, trichothecenes (satratoxin G and H, roridin A, isosatratoxin F), ochratoxin A, mycophenolic acid, gliotoxin, and fumonisin B1.
Key advantages over morphological methods:
Best use case: Clinically complex mold illness cases (CIRS, MCAS) where mycotoxin data is needed; distinguishing viable from non-viable mold burden; comprehensive species identification for remediation planning; cases where standard testing has been inconclusive.
Limitations: Higher cost. Tests a fixed panel — will not detect species outside the panel. Mycotoxin results from dust samples represent environmental load, not human exposure levels (which require urine/serum testing). Requires experienced clinician or IH to interpret mycotoxin results in clinical context. Not yet standardized across laboratories.
How it works: MSQPCR (Mold-Specific Quantitative PCR) is the analytical laboratory method the EPA uses to perform ERMI testing — not a separate test consumers order, but important to understand. Settled dust is homogenized, DNA is extracted, and species-specific quantitative PCR assays are run for all 36 ERMI species. Each assay uses primers targeting a unique DNA sequence (typically the ITS region or species-specific gene loci) and a fluorescent probe that emits signal proportional to the amount of target DNA amplified. The reaction is monitored in real-time, and a threshold cycle (CT value) inversely proportional to starting template quantity is used to calculate species concentration. Results are expressed as CE/mg dust (cell equivalents per milligram of dust).
Why it matters: MSQPCR is more reproducible, species-specific, and quantitatively precise than morphological counting methods. The EPA validated the method with a national reference dataset from 1,096 homes, establishing the statistical framework for ERMI score calculation and interpretation. Any laboratory offering "ERMI testing" should be using validated MSQPCR methodology on accredited equipment.
How it works: Urine mycotoxin analysis (most commonly via Real Time Laboratories, Great Plains Laboratory/Mosaic Diagnostics, or Vibrant Wellness) tests the patient's first-morning void urine for mycotoxin metabolites using liquid chromatography/tandem mass spectrometry (LC-MS/MS) or ELISA. The panels typically detect: ochratoxin A, aflatoxins (B1, B2, G1, G2), trichothecene metabolites (satratoxin G, deoxynivalenol, T-2 toxin), mycophenolic acid, gliotoxin, zearalenone, and fumonisin metabolites.
What it measures: Internal human mycotoxin body burden — evidence of mycotoxin exposure and retention, not just environmental presence. Elevated urine mycotoxin levels indicate that mycotoxins have been absorbed systemically through inhalation, ingestion, or skin contact. This is distinct from environmental testing and provides direct clinical data for patient management.
Clinical context: Urine mycotoxin testing is commonly used in the diagnosis and monitoring of Chronic Inflammatory Response Syndrome (CIRS) and mold toxin illness (biotoxin illness). Not covered by most insurance plans. Interpretation requires a clinician familiar with mold illness — elevated levels must be contextualized against the patient's symptoms, exposure history, and genetic susceptibility (HLA-DR testing for CIRS).
Limitations: Significant controversy in mainstream medicine regarding reference ranges, clinical significance thresholds, and the extent to which elevated urine mycotoxins indicate active building exposure versus dietary sources (many mycotoxins enter the food chain). Not regulated or standardized as rigorously as clinical chemistry panels. Should not be interpreted in isolation from environmental testing data.
How it works: Microbial volatile organic compounds (MVOCs) — characteristic metabolic byproducts of actively growing mold (1-octen-3-ol, 2-methylisoborneol, geosmin, etc.) — can be detected in air even when the mold source is completely hidden. Testing methods range from field instruments to laboratory analysis:
Best use case: Detecting hidden mold when building occupants report musty odors but no visible growth and air sampling is negative; characterizing the MVOC exposure burden for occupants with chemically sensitive or neurologically reactive presentations; confirming active (not historical) mold growth in areas inaccessible to visual or surface inspection.
Limitations: No standardized regulatory action levels for MVOCs — interpretation is qualitative and expert-dependent. Building chemistry (paints, cleaning products, off-gassing materials) creates background VOC interference. MVOC production is highly variable based on growth phase, temperature, and substrate. A negative MVOC result does not exclude mold — non-growing or recently dried mold may produce few MVOCs.
| Method | Sample Type | DIY Available? | Cost (Professional) | Cost (DIY) | Lab Turnaround | Species ID Precision | Best For |
|---|---|---|---|---|---|---|---|
| Air sampling (spore trap) | Air | No (pump required) | $75–$150/sample | N/A | 3–5 days | Genus level | Screening; post-remediation clearance |
| Andersen viable air | Air (cultured) | No | $150–$300/sample | N/A | 7–14 days | Species level | Occupational; viable-only count |
| Tape lift / surface swab | Surface | Yes (tape + mail) | $50–$100/sample | $30–$60 | 3–5 days | Genus/Species | Confirming visible mold; ID |
| Bulk sampling | Building material | Partial (collect + mail) | $75–$150/sample | $50–$100 | 3–7 days | Species level | Material penetration; remediation planning |
| ERMI (dust vacuum) | Settled dust | Yes (kit available) | $300–$500 | $200–$350 | 7–14 days | 36 species (PCR) | Historical whole-home burden; real estate |
| HERTSMI-2 (ERMI subset) | Settled dust | Yes (kit available) | $200–$300 | $150–$250 | 5–10 days | 5 species (PCR) | Re-occupancy decisions; CIRS management |
| qPCR / EMMA panel | Dust / air / surface | Partial (collect + mail) | $400–$700 | $300–$500 | 5–10 days | 12–15 species (PCR) | Clinical mold illness; mycotoxin co-testing |
| Urine mycotoxin panel | Human urine | Yes (mail-in) | $400–$800 | $300–$600 | 7–14 days | N/A (metabolites) | Human body burden; CIRS/mold illness |
| MVOC / VOC air | Air (VOCs) | No (PID) / Partial (Summa) | $200–$600 | N/A | 1 day–1 week | N/A (metabolites) | Hidden mold; musty odor investigation |
| DIY gravity plate kit | Air (settled) | Yes (retail) | N/A | $10–$50 | 72 hours | Very limited | NOT RECOMMENDED (see below) |
The ERMI scale runs from approximately −10 (extremely clean, dry building) to +20 (severely contaminated water-damaged building). The national reference distribution of 1,096 US homes tested by the EPA shows a rough bell curve centered near 0, with standard deviations of approximately 4–5 ERMI points.
Group 1 (26 species) — "Water Damage Indicators": These are molds not typically found in clean, dry buildings and are strongly associated with elevated moisture and water damage. Their presence in settled dust indicates past or present moisture problems. Key Group 1 species include: Aspergillus versicolor, Aspergillus penicillioides, Chaetomium globosum, Stachybotrys chartarum, Wallemia sebi, Eurotium amstelodami, Penicillium brevicompactum, Penicillium variabile, Scopulariopsis brevicaulis.
Group 2 (10 species) — "Reference Species": These molds are found in virtually all homes regardless of moisture status — they track outdoor air and represent background fungal ecology. Key Group 2 species include: Alternaria alternata, Cladosporium cladosporioides (type 1 and 2), Penicillium chrysogenum, Epicoccum nigrum, Mucor amphibiorum.
The ERMI score rises when Group 1 (water-damage) species are elevated relative to Group 2 (background) species — a pattern that reliably signals building moisture problems regardless of outdoor seasonal variation.
| HERTSMI-2 Score | Interpretation | Recommended Action |
|---|---|---|
| ≤11 | Acceptable for most occupants | No immediate action required; monitor if symptomatic occupants present |
| 12–15 | Caution zone | Sensitive individuals (CIRS patients, mold-sensitized asthmatics) should consider temporary relocation; investigate moisture sources |
| ≥16 | Remediation needed | Not safe for sensitive occupants; professional remediation required before re-occupancy of mold-illness patients |
Gravity-settle Petri dish kits — the type sold at hardware stores for $10–$40 — are the most widely purchased and most misleading mold test product on the market. Understanding why they fail prevents wasted money and false reassurance.
What they actually measure: The rate at which mold spores settle out of air under the influence of gravity onto a nutrient agar plate left open for a specified period (typically 1–48 hours). The plate is then sealed and incubated, and the user counts colonies visible after 48–72 hours.
Why this is not a useful measurement:
After professional mold remediation, independent clearance testing is required before containment is removed and re-occupancy resumes. This is a critical step that protects occupants and provides legal documentation for insurers and future property transactions.
The IICRC Standard for Professional Mold Remediation (S520, 4th Edition) specifies a two-component clearance requirement:
Clearance testing must be performed by an independent industrial hygienist who was not involved in the remediation work — the same contractor cannot both do the work and certify its completion. This independence requirement is enforced in most states and is required by most insurance companies for claim resolution.
| Credential | Full Name | Scope | Testing Authority |
|---|---|---|---|
| CIH | Certified Industrial Hygienist (ABIH) | Comprehensive environmental health and safety; full sampling authority; expert witness qualified | Highest — OSHA, legal, complex investigations |
| CMC | Certified Microbial Consultant (ACAC) | Mold assessment, sampling, and project design; does not perform remediation | High — independent assessment, clearance testing |
| CMRS | Certified Microbial Remediation Supervisor (ACAC) | Remediation supervision; may sample but has conflict-of-interest in clearance role | Moderate — remediation oversight, not clearance |
| CIEC | Council-Certified Indoor Environment Consultant (ACAC) | Broad IAQ assessment including mold; sampling authority | High — independent assessment |
| Licensed Mold Assessor (state-licensed) | Varies by state (FL, NY, TX, LA require licensure) | State-regulated; passed exam; cannot perform remediation in the same building | Required in licensed states |
| DIY sampling (homeowner) | N/A | Sample collection only; no assessment authority; chain-of-custody concerns | Limited — for initial screening only |
Mold test results are meaningless without context. The critical concept in indoor air quality assessment is comparison to outdoor baseline: indoor mold levels are expected to be somewhat lower than outdoor levels, and the predominant indoor genera should mirror outdoor genera (i.e., the building's air is a filtered version of outdoor air). Deviation from this baseline — higher indoor counts or indoor genera distinctly different from outdoors — signals an indoor mold source.
The EPA analyzed a nationally representative sample of 1,096 US homes for ERMI score distribution:
Homes with ERMI scores in the 90th–95th percentile (above approximately +8) were significantly overrepresented among asthmatic children's homes in the Inner-City Asthma Study, confirming that high ERMI scores are clinically meaningful markers of elevated asthma risk.
| Your Situation | Best Primary Test | Recommended Secondary Test | Who Should Collect |
|---|---|---|---|
| Musty odor, no visible mold, normal home | Air sampling (3-room + outdoor control) OR ERMI | MVOC analysis if air sampling negative | Certified IH or CMC |
| Visible mold — want to know species before remediating | Tape lift / surface swab from affected area | Air sampling for dispersal assessment | Certified inspector or DIY (tape lift) |
| Post-flood or major water damage | Air sampling (inside + outside + control rooms) | Bulk sampling of affected materials | Certified IH — mandatory for insurance |
| Buying or selling a home | ERMI (historical burden) + air sampling | HERTSMI-2 for health-sensitive occupants | Independent certified assessor |
| Post-remediation clearance | Air sampling per IICRC S520 | Surface swabs from remediated surfaces | Independent IH (not remediator) |
| Chronic illness — suspected mold exposure | ERMI + HERTSMI-2 (home burden) | qPCR/EMMA panel; urine mycotoxin (clinical) | ERMI DIY or IH; physician orders urine test |
| HVAC contamination suspected | Air sampling at supply registers | Swab sampling from coil or drain pan | Certified HVAC hygienist or IH |
| New construction — moisture issue | Bulk sampling of suspect materials | Air sampling for dispersal | Certified inspector |
| Rental property / landlord documentation | Air sampling + tape lift (visual confirmation) | ERMI for comprehensive record | Certified IH for legal defensibility |
DIY mold sample collection followed by accredited laboratory analysis is appropriate for initial screening and cost management in low-stakes situations. For insurance claims, real estate transactions, occupational health compliance, legal proceedings, or medical management of mold illness, professional collection by a certified industrial hygienist or mold assessor with documented chain-of-custody is required for results to have legal or clinical defensibility.